间充质干细胞对急性肾损伤治疗机制的研究进展

    Research advances on the mechanism of mesenchymal stem cells in the treatment of acute kidney injury

    • 摘要: 急性肾损伤(acute kidney injury,AKI)是一种常见的临床并发症,其病因复杂且预后差。尽管在肾脏支持性治疗方面取得重大进展,但AKI的患病率和病死率仍居高不下,并有持续上升趋势。间充质干细胞(mesenchymal stem cell,MSC)是再生医学中被深入研究的一种新型细胞,具有来源广泛、自我更新和免疫调节等特点。许多研究证明,MSC可能通过多种机制改善AKI模型中的肾脏损伤。以下就MSC治疗AKI的研究进行综述。

       

      Abstract: Acute kidney injury(AKI)is a common clinical complication with a complex etiology and a poor prognosis.Although significant advances have been achieved in renal supportive therapy,the prevalence and mortality of AKI remain consistently elevated.As a novel type of cell extensively examined in regenerative medicine,mesenchymal stem cell(MSC)has the unique characteristics of wide availability,self-renewal and immune regulation.Many studies have confirmed that MSC could improve renal injury through a variety of mechanisms in AKI model.This review summarized the latest researches on MSC in the treatment of AKI.

       

    /

    返回文章
    返回